[Clinical application of microfibrillar collagen hemostat (Avitene) in neurosurgical field]. 1988

N Nakamura, and T Hashimoto, and H Sakai, and S Yasue, and I Nagayama, and T Sasaki, and N Basugi, and K Kim, and K Kitamura, and M Yoshimasu
Department of Neurosurgery, Jikei University School of Medicine.

Microfibrillar collagen hemostat (Avitene) is a new absorbable hemostatic agent, of which mechanisms are adhesion to the bleeding site and platelet aggregation. Histopathological examinations revealed that Avitene was biocompatible with cerebral cortex in an animal experiments. Our previous studies indicated that Avitene is very effective and safe to use as a topical hemostatic agent during craniotomy in an experimental animal. Avitene was used as a topical hemostatic agent during craniotomy in 36 patients with intracranial organic lesions. Its effectiveness of hemostasis was revealed in 95%. This agent was especially useful to prevent oozing during craniotomy. Side effect of this agent was not reported in this study. Therefore, Avitene is very effective and safe to use as a topical hemostatic agent in the neurosurgical field.

UI MeSH Term Description Entries
D008297 Male Males
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D001932 Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. Brain Cancer,Brain Metastases,Brain Tumors,Cancer of Brain,Malignant Primary Brain Tumors,Neoplasms, Intracranial,Benign Neoplasms, Brain,Brain Neoplasm, Primary,Brain Neoplasms, Benign,Brain Neoplasms, Malignant,Brain Neoplasms, Malignant, Primary,Brain Neoplasms, Primary Malignant,Brain Tumor, Primary,Brain Tumor, Recurrent,Cancer of the Brain,Intracranial Neoplasms,Malignant Neoplasms, Brain,Malignant Primary Brain Neoplasms,Neoplasms, Brain,Neoplasms, Brain, Benign,Neoplasms, Brain, Malignant,Neoplasms, Brain, Primary,Primary Brain Neoplasms,Primary Malignant Brain Neoplasms,Primary Malignant Brain Tumors,Benign Brain Neoplasm,Benign Brain Neoplasms,Benign Neoplasm, Brain,Brain Benign Neoplasm,Brain Benign Neoplasms,Brain Cancers,Brain Malignant Neoplasm,Brain Malignant Neoplasms,Brain Metastase,Brain Neoplasm,Brain Neoplasm, Benign,Brain Neoplasm, Malignant,Brain Neoplasms, Primary,Brain Tumor,Brain Tumors, Recurrent,Cancer, Brain,Intracranial Neoplasm,Malignant Brain Neoplasm,Malignant Brain Neoplasms,Malignant Neoplasm, Brain,Neoplasm, Brain,Neoplasm, Intracranial,Primary Brain Neoplasm,Primary Brain Tumor,Primary Brain Tumors,Recurrent Brain Tumor,Recurrent Brain Tumors,Tumor, Brain
D002561 Cerebrovascular Disorders A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others. Brain Vascular Disorders,Intracranial Vascular Disorders,Vascular Diseases, Intracranial,Cerebrovascular Diseases,Cerebrovascular Insufficiency,Cerebrovascular Occlusion,Brain Vascular Disorder,Cerebrovascular Disease,Cerebrovascular Disorder,Cerebrovascular Insufficiencies,Cerebrovascular Occlusions,Disease, Cerebrovascular,Diseases, Cerebrovascular,Insufficiencies, Cerebrovascular,Insufficiency, Cerebrovascular,Intracranial Vascular Disease,Intracranial Vascular Diseases,Intracranial Vascular Disorder,Occlusion, Cerebrovascular,Occlusions, Cerebrovascular,Vascular Disease, Intracranial,Vascular Disorder, Brain,Vascular Disorder, Intracranial,Vascular Disorders, Brain,Vascular Disorders, Intracranial
D003094 Collagen A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). Avicon,Avitene,Collagen Felt,Collagen Fleece,Collagenfleece,Collastat,Dermodress,Microfibril Collagen Hemostat,Pangen,Zyderm,alpha-Collagen,Collagen Hemostat, Microfibril,alpha Collagen
D003399 Craniotomy Surgical incision into the cranium. Craniectomy,Craniectomies,Craniotomies
D004388 Dura Mater The outermost of the three MENINGES, a fibrous membrane of connective tissue that covers the brain and the spinal cord. Falx Cerebelli,Falx Cerebri,Pachymeninx,Tentorium Cerebelli
D005260 Female Females
D006490 Hemostatics Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming arterial or venous bleeding under any significant intravascular pressure. Antihemorrhagic,Hemostatic,Antihemorrhagics
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

N Nakamura, and T Hashimoto, and H Sakai, and S Yasue, and I Nagayama, and T Sasaki, and N Basugi, and K Kim, and K Kitamura, and M Yoshimasu
January 1982, The International journal of periodontics & restorative dentistry,
N Nakamura, and T Hashimoto, and H Sakai, and S Yasue, and I Nagayama, and T Sasaki, and N Basugi, and K Kim, and K Kitamura, and M Yoshimasu
April 1994, The Annals of thoracic surgery,
N Nakamura, and T Hashimoto, and H Sakai, and S Yasue, and I Nagayama, and T Sasaki, and N Basugi, and K Kim, and K Kitamura, and M Yoshimasu
December 1995, Archives of pathology & laboratory medicine,
N Nakamura, and T Hashimoto, and H Sakai, and S Yasue, and I Nagayama, and T Sasaki, and N Basugi, and K Kim, and K Kitamura, and M Yoshimasu
December 1994, The Journal of thoracic and cardiovascular surgery,
N Nakamura, and T Hashimoto, and H Sakai, and S Yasue, and I Nagayama, and T Sasaki, and N Basugi, and K Kim, and K Kitamura, and M Yoshimasu
January 2021, Medical devices (Auckland, N.Z.),
N Nakamura, and T Hashimoto, and H Sakai, and S Yasue, and I Nagayama, and T Sasaki, and N Basugi, and K Kim, and K Kitamura, and M Yoshimasu
April 2004, The Journal of thoracic and cardiovascular surgery,
N Nakamura, and T Hashimoto, and H Sakai, and S Yasue, and I Nagayama, and T Sasaki, and N Basugi, and K Kim, and K Kitamura, and M Yoshimasu
May 1981, Ophthalmology,
N Nakamura, and T Hashimoto, and H Sakai, and S Yasue, and I Nagayama, and T Sasaki, and N Basugi, and K Kim, and K Kitamura, and M Yoshimasu
October 2017, Neurology. Clinical practice,
N Nakamura, and T Hashimoto, and H Sakai, and S Yasue, and I Nagayama, and T Sasaki, and N Basugi, and K Kim, and K Kitamura, and M Yoshimasu
December 1979, Radiology,
N Nakamura, and T Hashimoto, and H Sakai, and S Yasue, and I Nagayama, and T Sasaki, and N Basugi, and K Kim, and K Kitamura, and M Yoshimasu
August 1993, Journal of laparoendoscopic surgery,
Copied contents to your clipboard!